Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28742898.
- Also identified by DOI 10.1001/jama.2017.7467 and PMC identifier 5817607.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses commercial pharmaceutical database data to evaluate the number of new drugs and vaccines for neglected tropical diseases entering phase 1 clinical trials before and after introduction in 2007 of a priority review voucher program to incentivize development.
Medical subject headings
- Orphan Drug Production
- Tropical Medicine